FDA Approved Medical Products for:

Acute myeloid leukemia, adult

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Idarubicin HCl for injection
Trade Name
(Manufacturer Name)
Idamycin®
(Pfizer)
Indication
The FDA has approved this product to be used in this manner.
Treatment of acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Sargramostim
Trade Name
(Manufacturer Name)
Leukine®
(Genzyme)
Indication
The FDA has approved this product to be used in this manner.
Following induction chemotherapy in older adult patients with acute myelogenous leukemia to shorten time to neutrophil recovery and to reduce the incidence of severe and life-threatening infections and infections resulting in death.
More Information about this product Drug Information Portal

Generic Name Gemtuzumab zogamicin
Trade Name
(Manufacturer Name)
Mylotarg®
(Wyeth Pharmaceuticals, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of patients with CD33 positive acute myeloid leukemia in first relapse who are 60 years of age or older and who are not considered candidates for cytotoxic chemotherapy
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Filgrastim
Trade Name
(Manufacturer Name)
Neupogen®
(Amgen, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Reducing the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of adults with acute myeloid leukemia.
More Information about this product Drug Information Portal

Generic Name Mitoxantrone HCl
Trade Name
(Manufacturer Name)
Novantrone® (injection)
((OSI) Pharmaceuticals)
Indication
The FDA has approved this product to be used in this manner.
Treatment of acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.
More Information about this product Drug Information Portal